News - BioPharm International



FDA Issues Guidance on Expedited Programs for Serious Conditions

May 30, 2014

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

Bristol-Myers Squibb Enters Cancer Research Collaborations

May 29, 2014

Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.

Array BioPharma and Biogen Idec Collaborate on Kinase Inhibitors

May 29, 2014

The companies aim to discover and develop kinase inhibitors for treating autoimmune disorders.

FDA Targets Illegal Online Pharmacies

May 27, 2014

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

Merck KGaA Invests in Biopharmaceuticals Fill-Finish Site

May 22, 2014

Merck KGaA fill-finish expansion in Italy will be completed in 2017.

FDA Approves Entyvio for Ulcerative Colitis and Crohn's Disease

May 21, 2014

DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

SAFC Installs Continuous-Flow Reactor

May 21, 2014

SAFC offers commercial and pilot-scale continuous-flow capacity.

AstraZeneca Rejects Pfizer's Final Offer

May 19, 2014

AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.

FDA and EMA Join Forces on Treatment of Gaucher Disease in Children

May 15, 2014

FDA and EMA release a draft joint proposal on the development of new drugs to treat Gaucher disease in children.



Click here